mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.3 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.3 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |